Literature DB >> 8120537

Modulation of MHC class II expression in the absence of lymphocytic infiltrates in Alzheimer's retinae.

S C Liew1, P L Penfold, J M Provis, M C Madigan, F A Billson.   

Abstract

This study describes the expression of MHC class II antigens in retinal flat mounts from normal donors and patients with Alzheimer's disease (AD). We confirm previous observations of MHC class II immunoreactivity on microglia in normal retinae, while observing insignificant levels of reactivity on endothelial cells (EC). A significantly increased level of MHC class II expression was detected in AD retinae. This increased immunoreactivity was found to occur in the absence of lymphocytic infiltrates, suggesting that the pathogenesis of AD in the retina may be distinct from that reported to occur in some regions of the brain. MHC class II expression, measured using computerized optical densitometry, appeared to be increased principally as a result of induced MHC class II immunoreactivity on EC. Ramified microglia and perivascular macrophages, although hypertrophied, appeared to show unchanged levels of MHC class II expression. These findings are consistent with earlier suggestions that both aberrant MHC class II expression and suppressor activity of resident macrophages may restrict immune responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8120537     DOI: 10.1097/00005072-199403000-00006

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  6 in total

1.  The influence of penetrating keratoplasty and cyclosporin A therapy on MHC class II (Ia)-positive cells in the rat iris and choroid.

Authors:  S E Coupland; L Krause; F Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-02       Impact factor: 3.117

2.  Inflammatory changes parallel the early stages of Alzheimer disease.

Authors:  A Parachikova; M G Agadjanyan; D H Cribbs; M Blurton-Jones; V Perreau; J Rogers; T G Beach; C W Cotman
Journal:  Neurobiol Aging       Date:  2006-10-18       Impact factor: 4.673

3.  Microglial recruitment, activation, and proliferation in response to primary demyelination.

Authors:  Leah T Remington; Alicia A Babcock; Simone P Zehntner; Trevor Owens
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

4.  Retina and Brain Display Early and Differential Molecular and Cellular Changes in the 3xTg-AD Mouse Model of Alzheimer's Disease.

Authors:  Ana Catarina Rodrigues-Neves; Rafael Carecho; Sónia Catarina Correia; Cristina Carvalho; Elisa Julião Campos; Filipa Isabel Baptista; Paula Isabel Moreira; António Francisco Ambrósio
Journal:  Mol Neurobiol       Date:  2021-02-19       Impact factor: 5.590

5.  CD45RB is a novel molecular therapeutic target to inhibit Abeta peptide-induced microglial MAPK activation.

Authors:  Yuyan Zhu; Huayan Hou; William V Nikolic; Jared Ehrhart; Elona Rrapo; Paula Bickford; Brian Giunta; Jun Tan
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

Review 6.  Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.

Authors:  Maria H Madeira; Raquel Boia; António F Ambrósio; Ana R Santiago
Journal:  Mediators Inflamm       Date:  2017-01-31       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.